MSD Gulf Commited to bringing out the best in medicine
Contact UsMerck Worldwide
   
Healthcare Professionals MSD Gulf About Us Products Contact us
Email Updates
Request More Information


SINGULAIR for Asthma - SINGULAIR vs. ICS Alone

IN A MULTICENTER, RANDOMIZED PARALLEL-GROUP STUDY OF
782 ADULTS WITH ASTHMA WHO RECEIVED SIX WEEKS OF DOUBLE-BLIND
TREATMENT, SINGULAIR PROVIDED EFFICACY COMPARABLE TO AN
INHALED STEROID15a
Results shown in graph are modified from study report of 97+0.9%, 96.1+1%, and 91.9+2.6%, respectively, with asthma attacks.
Adapted from Israel E et al J Allergy Clin Immunol 2002;110(6):847–854.
See Study Design A
NO SIGNIFICANT DIFFERENCE BETWEEN SINGULAIR
AND BECLOMETHASONE GROUPS IN:
  • Asthma control days15c
  • Rescue corticosteroid use15
  • Daily beta2-agonist use (albuterol)15
bid=twice daily
a Double-blind treatment consisted of SINGULAIR 10 mg once daily in the evening, beclomethasone 200 µg twice daily, or placebo.15
bp=0.488 for SINGULAIR vs. beclomethasone15
cAn asthma control day was defined as a day with two or less inhalations of albuterol (including those for exercise prophylaxis), no nighttime awakenings, and no asthma attacks. An asthma attack was defined as worsening asthma resulting in an unscheduled visit to the doctor's office or an emergency department, hospitalization, or treatment with oral corticosteroids.15
View referencesView References PrintPrint

Before prescribing, please consult the full product circular.
† Trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA

Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA) Disclaimer